Key statistics
As of last trade Akari Therapeutics PLC (CLA:DEU) traded at 2.86, -28.14% below its 52-week high of 3.98, set on Jul 29, 2024.
52-week range
Open | 2.76 |
---|---|
High | 2.88 |
Low | 2.76 |
Bid | 2.78 |
Offer | 2.96 |
Previous close | 2.92 |
Average volume | 32.90 |
---|---|
Shares outstanding | 607.23k |
Free float | 485.78k |
P/E (TTM) | -- |
Market cap | 38.38m USD |
EPS (TTM) | -2.98 USD |
Data delayed at least 15 minutes, as of Sep 19 2024.
More ▼
Announcements
- Rob Bazemore Appointed to the Board of Directors of Akari Therapeutics
- Akari Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights
- Akari Therapeutics Receives Positive and Constructive Pre-IND Feedback from US FDA for PAS-nomacopan in Treatment of Geographic Atrophy
- Akari Therapeutics Announces Interim CEO Employment Contract Demonstrating Alignment with Shareholders
- Akari Therapeutics Secures $7.6 Million in Upsized Financing Round
- Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
- Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
- Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
- Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024
- Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights
More ▼